DRAPER, Utah, May 8 /PRNewswire-FirstCall/ -- 1-800 CONTACTS, INC.
(Nasdaq: CTAC) ("the Company") today reported results for its first quarter
ended March 31, 2007.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040107/LACONTACTSLOGO)
First Quarter Results
Consolidated net sales for the first quarter ended March 31, 2007 were
$67.4 million, compared to $63.5 million for the comparable quarter of the
prior year. For the first quarter of fiscal 2007, the Company reported a
consolidated net loss of $(1.0) million, or $(0.08) per diluted common
share, compared to consolidated net income of $1.2 million, or $0.09 per
diluted common share, for the first quarter of fiscal 2006.
U.S. Retail
Net sales and operating income for the Company's U.S. retail business
for the first quarter of fiscal 2007 were $61.8 million and $6.2 million,
respectively, compared to net sales of $59.2 million and operating income
of $7.0 million for the first quarter of fiscal 2006. Results for the first
quarter of fiscal 2007 include approximately $0.4 million in legal and
professional expenses relating to the strategic review of ClearLab and the
U.S. retail business.
Gross margin for the Company's U.S. retail business increased to 40.2%
for the first quarter of fiscal 2007 from 39.9% for the first quarter of
fiscal 2006.
Advertising expense for the first quarter of fiscal 2007 was $0.4
million more than for the first quarter of fiscal 2006.
During the first quarter of fiscal 2007, other selling, general and
administrative expenses as a percentage of net sales for the U.S. retail
business increased to 20.6% from 19.8% in the first quarter of fiscal 2006.
ClearLab
Net sales and operating loss for ClearLab, the Company's international
contact lens manufacturing business, for the first quarter of fiscal 2007
were $5.6 million and $(4.2) million, respectively, compared to net sales
of $4.3 million and an operating loss of $(2.9) million for the first
quarter of fiscal 2006. The results for the first quarter of fiscal 2007
include $1.0 million in license fees from the Company's Japanese license
agreement compared to $1.5 million in the first quarter of fiscal 2006.
Compared to the first quarter of fiscal 2006, ClearLab's operating
results for the first quarter of fiscal 2007 include the same level of
research and development expense, a $0.3 million increase in other selling,
general and administrative expenses, and $0.1 million for severance and
retention costs related to the closure of the United Kingdom manufacturing
operations.
Strategic Review
Jonathan Coon, Chief Executive Officer, remarked, "In March, we
indicated that a separation of ClearLab is likely to be accomplished in two
separate transactions -- one for the flat pack technology and one for
ClearLab's Singapore operation. We are pleased to announce that we have
entered into a Memorandum of Understanding (MOU) to sell ClearLab's
Singapore operation to Mi Gwang Contact Lens Co., Ltd., a Korean based
contact lens manufacturer. This MOU includes a $1 million break-up fee that
is applicable if either party does not execute a definitive purchase
agreement. We expect to execute a purchase agreement this month and to
close the transaction before the end of June."
"We are still considering whether to sell the current Japanese license
agreement and exclusive worldwide rights to the flat pack technology or
retain the current Japanese license agreement and the flat pack technology
and pursue a strategy of non-exclusive licenses with multiple
manufacturers. We expect to announce either a transaction for the flat pack
technology or a decision to retain the technology and the Japanese license
agreement soon."
"There can be no assurance that either of these transactions will be
completed. However, if completed, the combination of transactions would
provide sufficient cash at closing to allow us to retire our outstanding
indebtedness, including our line of credit and long term debt. We believe
these transactions, if executed, will also provide a tax benefit and
ongoing future consideration."
Concurrently with the strategic review of ClearLab, we are continuing
our strategic review of the U.S. retail business.
Outlook
For the second quarter of fiscal 2007, the Company expects U.S. retail
net sales of approximately $62 million to $63 million and operating income
of approximately $6 million. These results will continue to reflect the
costs associated with the strategic review. The Company's President, Brian
Bethers, added, "We are reconfirming our prior fiscal year 2007 guidance of
retail sales of $240 to $250 million and operating income of $23 million to
$26 million. Based on our first quarter results, we believe we will be in
the upper end of this range."
Mr. Bethers further stated, "ClearLab's second quarter results will
include costs relating to the closure of the United Kingdom manufacturing
operations and the consolidation in Singapore. We expect to incur up to
$3.0 million more in costs relating to the consolidation of operations in
Singapore during fiscal 2007."
"Excluding the anticipated $1.9 to $3.4 million of additional cash
expenditures related to the UK closure, we are reconfirming our previous
estimated cash funding requirements for ClearLab operations and R&D from
1-800 CONTACTS to be approximately $2.5 million for the second quarter of
fiscal 2007."
About 1-800 CONTACTS, INC.
1-800 CONTACTS offers consumers an attractive alternative for obtaining
replacement contact lenses in terms of convenience, price, and speed of
delivery. Through its easy-to-remember, toll-free telephone number, "1-800
CONTACTS" (1-800-266-8228), and its Internet web site,
http://www.1800contacts.com, the Company sells all of the popular brands of
contact lenses. 1-800 CONTACTS offers products at competitive prices, while
delivering a high level of customer service.
ClearLab develops and manufactures a wide range of disposable contact
lens products and distributes these lenses in markets outside of the United
States. More information about ClearLab can be found at its website,
http://www.clearlab.com.
Forward-looking Statements
This press release contains a number of statements about the Company's
future business prospects which are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include all statements which are not purely
historical and include, but are not necessarily limited to, all statements
relating to the potential separation of ClearLab from the U.S. retail
business (including all statements relating to the structure, timing,
break-up fee, or potential consideration or tax benefits relating to any
potential transaction(s)); the Company's belief that the potential ClearLab
transactions, if completed, could provide sufficient cash at closing to
allow the Company to retire its outstanding indebtedness or could otherwise
add significant future value; all statements relating to the potential sale
or retention of the Japanese license agreement and the flat pack
technology; all statements relating to the strategic review of the U.S.
retail business and anticipated costs associated with that review; expected
U.S. retail net sales and operating income for the second quarter of fiscal
year 2007 and for fiscal year 2007; estimated costs of the closure of the
United Kingdom manufacturing operations and the consolidation of such
operations in Singapore; the timing of the consolidation; and ongoing cash
funding requirements for ClearLab. All such forward-looking statements are
based upon information available to the Company as of the date hereof, and
the Company disclaims any intention or obligation to update any such
forward-looking statements. Actual results could differ materially from
current expectations. Factors that could cause or contribute to such
differences include, among others: general economic conditions; the health
and size of the contact lens industry; consumer acceptance of the Company's
and ClearLab's products; product health benefits; the outcome of the
strategic review of ClearLab and the U.S. retail business; supply risks;
inventory acquisition and management; manufacturing operations;
governmental regulations; exchange rate fluctuations; unanticipated costs
and expected benefits associated with the Japanese license agreement and
the Company's supply agreements and related arrangements; research and
development initiatives; prescription verification requirements of The
Fairness to Contact Lens Consumers Act; other regulatory considerations;
and the other risks and uncertainties identified in the reports filed from
time to time by the Company with the U.S. Securities and Exchange
Commission, including the Company's most recent Annual Report on Form 10-K
and Quarterly Reports on Form 10-Q. Information on the Company's websites,
other than the information specifically referenced in this press release,
shall not be deemed to be part of this press release.
1-800 CONTACTS, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS INFORMATION
(in thousands, except per share amounts)
(unaudited)
Quarter Ended
April 1, March 31,
2006 2007
NET SALES $63,491 $67,421
COST OF GOODS SOLD 39,013 43,049
Gross profit 24,478 24,372
SELLING, GENERAL & ADMINISTRATIVE
EXPENSES:
Advertising 3,983 4,421
Legal and professional 1,125 1,630
Research and development 1,328 1,251
Restructuring charges -- 110
Other selling, general & administrative 13,679 14,963
Total selling, general &
administrative expenses 20,115 22,375
INCOME FROM OPERATIONS 4,363 1,997
OTHER INCOME (EXPENSE), net 313 (350)
INCOME BEFORE PROVISION
FOR INCOME TAXES 4,676 1,647
PROVISION FOR INCOME TAXES (3,495) (2,659)
NET INCOME (LOSS) $1,181 $(1,012)
PER SHARE INFORMATION:
Basic and diluted net income
(loss)
per common share $0.09 $(0.08)
WEIGHTED AVERAGE NUMBER
OF COMMON SHARES OUTSTANDING:
Basic 13,345 13,420
Diluted 13,441 13,420
OTHER DATA:
Depreciation $1,388 $1,711
Amortization 910 800
Total depreciation and
amortization $2,298 $2,511
Depreciation and amortization
included in the following captions:
Cost of goods sold $770 $756
Research and development 49 229
Other selling, general & administrative 1,479 1,526
Total depreciation and amortization $2,298 $2,511
SEGMENT INFORMATION:
Quarter Ended
April 1, 2006
Inter- Elimi-
U.S. national nations Total
Net sales $59,173 $4,318 $-- $63,491
Gross profit (loss) 23,624 638 216 24,478
Research and development 10 1,318 -- 1,328
Restructuring charges -- -- -- --
Other selling, general &
administrative 11,713 1,966 -- 13,679
Income (loss) from operations 7,006 (2,859) 216 4,363
Depreciation and amortization $1,256 $1,042 $-- $2,298
Quarter Ended
March 31, 2007
Inter- Elimi-
U.S. national nations Total
Net sales $61,829 $5,592 $-- $67,421
Gross profit (loss) 24,829 (457) -- 24,372
Research and development -- 1,251 -- 1,251
Restructuring charges -- 110 -- 110
Other selling, general &
administrative 12,710 2,253 -- 14,963
Income (loss) from operations 6,176 (4,179) -- 1,997
Depreciation and amortization $1,317 $1,194 $-- $2,511
1-800 CONTACTS, INC.
CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION
(in thousands)
(unaudited)
ASSETS
December 30, March 31,
2006 2007
CURRENT ASSETS:
Cash $2,737 $616
Accounts receivable, net 3,577 3,711
Inventories, net 24,325 23,738
Deferred income taxes 1,886 1,766
Other current assets 4,641 3,350
Total current assets 37,166 33,181
PROPERTY, PLANT AND EQUIPMENT, net 27,555 26,425
DEFERRED INCOME TAXES 898 920
GOODWILL 22,304 22,304
DEFINITE-LIVED INTANGIBLE ASSETS, net 11,500 10,969
OTHER ASSETS 1,102 912
Total assets $100,525 $94,711
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt 2,633 2,476
Current portion of capital lease
obligations 57 27
Accounts payable and accrued
liabilities 24,904 24,422
Total current liabilities 27,594 26,925
LONG-TERM LIABILITIES:
Line of credit 29,970 26,144
Long-term debt, net of current portion 4,404 3,934
Capital lease obligations, net of
current portion 35 29
Other long-term liabilities 844 226
Total long-term liabilities 35,253 30,333
STOCKHOLDERS' EQUITY 37,678 37,453
Total liabilities and
stockholders' equity $100,525 $94,711
SOURCE 1-800 CONTACTS, INC.
 back to top
Related links:
http://www.1800contacts.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20040107/LACONTACTSLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Brian W. Bethers, President, or Robert G.
Hunter, Chief Financial Officer, both of 1-800 CONTACTS,
+1-801-316-5000, investors@1800contacts.com
|
